NasdaqGS:IONSBiotechs
Is It Too Late To Consider Ionis Pharmaceuticals (IONS) After A 150% One Year Surge?
If you are wondering whether Ionis Pharmaceuticals at around US$74.09 is priced for more growth or already reflects the story, the key is to look carefully at what the current valuation actually implies.
The stock has had a mixed recent run, with a 1.6% decline over the last 7 days, a 6.3% gain over the past month, a 7.0% decline year to date, and a 150.6% return over the last year that may have reshaped expectations and perceived risk.
Recent coverage around Ionis has focused on its...